S. boulardii CNCM I-745.

The two occupy different niches: a yeast that is not affected by antibacterial pressure and a lactic acid bacterium that colonises transiently and lowers luminal pH. Combining them broadens the range of conditions under which at least one member stays viable.

S. boulardii is a yeast and does not compete with lactobacilli for the same substrates or adhesion sites. That non-overlap is why the two are routinely blended in one capsule.

Bifidobacteria ferment oligosaccharides into short-chain fatty acids in the colon while the yeast acts in the small intestine and secretes proteases at the mucosal surface. The two act at different sites of the same tract.

Glutamine is the preferred fuel of the enterocyte and supports normal tight junction protein expression. It works on the host side of the same barrier that the yeast supports from the lumen.

Zinc carnosine adheres to the mucosal surface and supports normal epithelial repair and mucus quality. That is complementary to a yeast acting in the lumen rather than on the epithelium.

Butyrate is the main energy source of the colonocyte and supports barrier integrity, and S. boulardii shifts the flora toward more butyrate-producing species. Supplying it directly covers the same endpoint from the other side.

A yeast and a lactic acid bacterium occupy different niches and are unaffected by each other's growth requirements. Multi-strain products combine them for that complementarity, and the yeast is unaffected by antibacterial agents that would suppress the bacterium. The combination itself has not been isolated as a variable in the located sources.

Bifidobacteria are strict colonisers of the colon while this yeast passes through transiently without colonising. The two therefore act at different points and on different timescales. Products pair them on that reasoning rather than on a head-to-head combination trial.

Caprylic acid disrupts fungal cell membranes and has documented activity against Saccharomyces and other yeasts in culture. Taken at the same time as a live yeast preparation it can reduce the number of viable organisms delivered. This is an anti-synergy worth flagging on a label, and separating the doses is the usual response.

Carvacrol and thymol permeabilise fungal membranes and inhibit Saccharomyces in vitro. A concentrated oregano oil taken alongside a live yeast preparation works against it rather than with it. The in vitro activity is well described; the extent of the effect in the gut has not been quantified in the located sources.

Allicin and its breakdown products inhibit yeast growth in culture through thiol-reactive chemistry. High-allicin garlic preparations therefore sit in tension with a live yeast product taken at the same moment. Ordinary culinary garlic is a different proposition from a concentrated extract.

Berberine shows broad antimicrobial activity in culture that includes yeasts as well as bacteria. Co-dosing with a live organism is at least theoretically self-defeating. The magnitude at oral intakes in the gut lumen has not been measured, so this is a caution rather than a finding.

Activated charcoal adsorbs a wide range of organic material in the gut lumen, and a live preparation taken in the same window is caught up in that non-selective binding. Standard practice is to separate any charcoal dose from other oral products by a couple of hours. The same logic applies to bentonite clay.

Clay binders act by surface adsorption and ion exchange and do not discriminate between what they bind. Dosing them together with a live yeast preparation reduces what actually reaches the intestine. Spacing the two is the practical answer.

Zinc is required for normal enterocyte turnover and tight-junction protein assembly, an established nutritional relationship. The yeast is studied for its own effects on barrier markers. The two act on the same tissue by different routes, and the combination has not been isolated in the located literature.

Lactoferrin sequesters free iron in the gut lumen and limits the growth of iron-dependent organisms while leaving the yeast unaffected, since Saccharomyces has its own iron-uptake systems. The pairing is a rational one on those grounds. No combination study was located.

Bovine colostrum supplies immunoglobulins and growth factors that act in the gut lumen, and the yeast is studied for effects on secretory IgA and barrier markers. The rationale is complementary rather than overlapping. Nothing in the located sources tests them together.

Soluble fibre is fermented by the bacterial community to short-chain fatty acids, which is a bacterial process rather than a yeast one, since this organism does not depend on those substrates. The pairing supports the resident bacteria alongside a transient yeast. Calling the fibre a prebiotic for the yeast itself would be wrong.

Inulin feeds bifidobacteria and other fructan-fermenting bacteria; the yeast is not a fructan fermenter and takes no direct benefit. What the pairing does is combine a transient organism with substrate for the resident community. That is a real formulation logic and not a synergy in the strict sense.

Psyllium forms a viscous gel that holds water and increases stool bulk, an established physical effect independent of any microbe. It is combined with live preparations for that complementary, non-microbial mechanism. The two do not interact chemically.

This yeast is studied for effects on brush-border disaccharidase activity, and supplemental lactase performs the same hydrolysis directly in the lumen. The two reach the same end point by different routes. The enzyme's own action is established; the yeast's effect on enzyme activity is a measured marker in the research literature.

The Saccharomyces cell wall is built largely from beta-1,3 and beta-1,6 glucans and mannoproteins, which are the same structures isolated and sold as yeast beta-glucan. A live preparation therefore delivers those wall polysaccharides along with the living organism. Isolated beta-glucan supplies the structure without the viability.

Vitamin D receptor signalling is part of normal intestinal immune regulation and epithelial barrier maintenance. That role is established for vitamin D on its own. No study pairing it with this yeast strain was located, so the row records a plausible complement rather than a measured one.